Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Sell
46,088
-10,370
-18% -$1.03M 0.01% 736
2026
Q1
$5.31M Buy
+56,458
New +$5.63M 0.01% 691
2025
Q3
$1.92M Buy
+22,648
New +$1.79M 0.01% 594

Other funds holding INCY

CIBC Bancorp USA's INCY Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Incyte (INCY) stake by 18% in Q2 2026, selling an estimated $1.03M and leaving 46,088 shares worth $5.22M. The position accounts for 0.01% of the portfolio, ranked #736.

CIBC Bancorp USA first reported a position in INCY in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.31M in Q1 2026. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • CIBC Bancorp USA held 46,088 shares of Incyte worth $5.22M as of Q2 2026.
  • CIBC Bancorp USA sold 10,370 Incyte shares in Q2 2026, an estimated $1.03M.
  • Incyte made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #736 holding.
  • CIBC Bancorp USA first reported a position in Incyte in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Incyte position peaked at $5.31M in Q1 2026.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.